HomeCompareVOBIF vs JNJ

VOBIF vs JNJ: Dividend Comparison 2026

VOBIF yields 425.53% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VOBIF wins by $18058.56M in total portfolio value
10 years
VOBIF
VOBIF
● Live price
425.53%
Share price
$0.47
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18058.60M
Annual income
$12,349,610,253.13
Full VOBIF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — VOBIF vs JNJ

📍 VOBIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVOBIFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VOBIF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VOBIF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VOBIF
Annual income on $10K today (after 15% tax)
$36,170.21/yr
After 10yr DRIP, annual income (after tax)
$10,497,168,715.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, VOBIF beats the other by $10,497,164,729.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VOBIF + JNJ for your $10,000?

VOBIF: 50%JNJ: 50%
100% JNJ50/50100% VOBIF
Portfolio after 10yr
$9029.31M
Annual income
$6,174,807,471.26/yr
Blended yield
68.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VOBIF
No analyst data
Altman Z
9.0
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VOBIF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVOBIFJNJ
Forward yield425.53%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$18058.60M$30.3K
Annual income after 10y$12,349,610,253.13$4,689.40
Total dividends collected$17541.95M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VOBIF vs JNJ ($10,000, DRIP)

YearVOBIF PortfolioVOBIF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$53,253$42,553.19$10,592$272.30+$42.7KVOBIF
2$268,765$211,784.42$11,289$357.73+$257.5KVOBIF
3$1,286,515$998,936.38$12,123$472.89+$1.27MVOBIF
4$5,845,421$4,468,849.76$13,141$629.86+$5.83MVOBIF
5$25,230,957$18,976,356.52$14,408$846.81+$25.22MVOBIF
6$103,547,438$76,550,313.71$16,021$1,151.60+$103.53MVOBIF
7$404,404,397$293,608,638.27$18,122$1,588.22+$404.39MVOBIF
8$1,504,383,912$1,071,671,207.21$20,930$2,228.20+$1504.36MVOBIF
9$5,335,499,864$3,725,809,078.26$24,792$3,191.91+$5335.48MVOBIF
10$18,058,595,107$12,349,610,253.13$30,274$4,689.40+$18058.56MVOBIF

VOBIF vs JNJ: Complete Analysis 2026

VOBIFStock

Vobile Group Limited, an investment holding company, provides software as a service in the United States, Japan, Mainland China, and internationally. The company offers online video content protection and monetization services for content owners to protect their content from unauthorized use, measure the viewership of their content, and monetize their content. It provides content protection, measurement, and management and monetization platforms, as well as pay per transaction platforms. The company serves film studios, TV networks, record labels, DTC service providers, subscription video-on-demand content aggregators, sports leagues, toys and games companies, and other content owners. Vobile Group Limited was founded in 2005 and is headquartered in Causeway Bay, Hong Kong

Full VOBIF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VOBIF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VOBIF vs SCHDVOBIF vs JEPIVOBIF vs OVOBIF vs KOVOBIF vs MAINVOBIF vs ABBVVOBIF vs MRKVOBIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.